In The News Posted January 31, 2019 Share Posted January 31, 2019 NEW YORK, Jan. 30, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Immunomedics, Inc. ("Immunomedics" or the "Company") (NASDAQ:IMMU). If you invested in Immunomedics stock or options and would like to discuss... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.